| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1747-4949.2012.00851.X |
| P8608 | Fatcat ID | release_gm2pcenbnrfetazihuykosf64i |
| P698 | PubMed publication ID | 22863197 |
| P50 | author | Daniel Czuriga | Q44386909 |
| P2093 | author name string | Dániel Bereczki | |
| Natan M Bornstein | |||
| László Csiba | |||
| Katalin Réka Kovács | |||
| P2860 | cites work | Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study | Q24658404 |
| Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention | Q28168588 | ||
| Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy | Q30493660 | ||
| Silent brain infarcts: a systematic review | Q31116425 | ||
| Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes | Q33556775 | ||
| Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population | Q33670582 | ||
| Silent brain infarcts: a review of MRI diagnostic criteria | Q33843126 | ||
| Silent cerebral events in asymptomatic carotid stenosis. | Q33948924 | ||
| Plasma homocysteine as a risk factor for dementia and Alzheimer's disease | Q33957399 | ||
| Hemostatic factors and subclinical brain infarction in a community-based sample: the ARIC study | Q34037922 | ||
| Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium | Q34071362 | ||
| Obstructive sleep apnea: implications for cardiac and vascular disease | Q34268299 | ||
| Obstructive sleep apnea as a risk factor for stroke and death | Q34466726 | ||
| Acrolein, IL-6 and CRP as markers of silent brain infarction | Q34816996 | ||
| Significant association of metabolic syndrome with silent brain infarction in elderly people. | Q34987318 | ||
| Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study. | Q35034847 | ||
| Chronic kidney disease: effects on the cardiovascular system | Q36868237 | ||
| Relationship between silent brain infarction and chronic kidney disease | Q37090801 | ||
| Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study | Q37265840 | ||
| Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study | Q37359833 | ||
| Plasma fibrinogen and coronary heart disease in urban Japanese | Q39546650 | ||
| Carotid plaque texture analysis can predict the incidence of silent brain infarcts among patients undergoing carotid endarterectomy. | Q39743004 | ||
| High levels of serum uric acid are associated with silent brain infarction | Q39851651 | ||
| Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus | Q40341902 | ||
| Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability | Q40434935 | ||
| Silent MRI infarcts and the risk of future stroke: the cardiovascular health study | Q40682480 | ||
| Soluble P-selectin and the risk of future cardiovascular events | Q40729226 | ||
| Anticoagulation in dilated cardiomyopathy | Q41731227 | ||
| Silent brain infarction and rapid decline of kidney function in patients with CKD: a prospective cohort study | Q43033495 | ||
| Sex differences in the risk profile and male predominance in silent brain infarction in community-dwelling elderly subjects: the Sefuri brain MRI study | Q43079071 | ||
| Association of kidney dysfunction with silent lacunar infarcts and white matter hyperintensity in the general population: the Ohasama study. | Q43079190 | ||
| Hyperhomocysteinemia as an independent risk factor for silent brain infarction | Q43470505 | ||
| Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence | Q43706940 | ||
| Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study | Q43978616 | ||
| Association between cholesterols, homocysteine and silent brain infarcts | Q44071299 | ||
| Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study | Q44307042 | ||
| Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. | Q44353743 | ||
| Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study | Q44503850 | ||
| Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study | Q44648549 | ||
| Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system | Q45003611 | ||
| Elevated risk of stroke among patients with end-stage renal disease. | Q45168919 | ||
| Metabolic syndrome: definition, pathophysiology, and mechanisms | Q45230910 | ||
| Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients | Q45248514 | ||
| Relationship between nocturnal blood pressure variation and silent cerebral infarction in Chinese hypertensive patients | Q46322469 | ||
| Lipoprotein (a) as a risk factor for silent cerebral infarction in hemodialysis patients | Q46357368 | ||
| Homocysteine and cognitive performance in the Framingham offspring study: age is important | Q46656457 | ||
| Metabolic syndrome is associated with silent ischemic brain lesions | Q46716178 | ||
| Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects | Q46757624 | ||
| High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis | Q46851317 | ||
| Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. | Q46864816 | ||
| Late evaluation of silent cerebral ischemia detected by diffusion-weighted MR imaging after filter-protected carotid artery stenting | Q47750510 | ||
| Increased expression of ICAM-1 during reoxygenation in brain endothelial cells | Q48101185 | ||
| Predictive variables for mortality after acute ischemic stroke | Q48195369 | ||
| Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis | Q48196298 | ||
| Silent brain infarction and platelet activation in obstructive sleep apnea | Q48251845 | ||
| Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1. | Q48288595 | ||
| Retinopathy as an indicator of silent brain infarction in asymptomatic hypertensive subjects. | Q48332175 | ||
| Severe sleep apnea and risk of ischemic stroke in the elderly. | Q48455002 | ||
| Distinct location of subcortical silent infarcts compared with symptomatic lacunar infarcts | Q48472828 | ||
| Low-density lipoprotein subfractions and the prevalence of silent lacunar infarction in subjects with essential hypertension | Q48474984 | ||
| Hyperhomocysteinemia is a significant risk factor for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis | Q48572291 | ||
| Subcortical silent brain infarction as a risk factor for clinical stroke | Q48613109 | ||
| Association of hemostatic variables with MRI-detected cerebral abnormalities: the atherosclerosis risk in communities study | Q48875359 | ||
| Cerebro- and cardiovascular reactivity and neuropsychological performance in hypertensive patients | Q49067244 | ||
| Association between VEGF polymorphisms and homocysteine levels in patients with ischemic stroke and silent brain infarction | Q49076803 | ||
| Adults with late stage 3 chronic kidney disease are at high risk for prevalent silent brain infarction: a population-based study | Q49132565 | ||
| Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. | Q51036791 | ||
| Left ventricular filling in dilated cardiomyopathy: relation to functional class and hemodynamics. | Q52866424 | ||
| Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study. | Q53039723 | ||
| Practice Guidelines For Primary Care Physicians | Q57605484 | ||
| Nonfasting Plasma Total Homocysteine Levels and Stroke Incidence in Elderly Persons: The Framingham Study | Q57746002 | ||
| Silent Brain Infarction and Subcortical White Matter Lesions Increase the Risk of Stroke and Mortality: A Prospective Cohort Study | Q58455771 | ||
| Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 334-347 | |
| P577 | publication date | 2012-08-01 | |
| P1433 | published in | International Journal of Stroke | Q15763625 |
| P1476 | title | Silent brain infarction--a review of recent observations | |
| P478 | volume | 8 |
| Q41183754 | Association between subclinical carotid atherosclerosis, hyperhomocysteinaemia and mild cognitive impairment |
| Q48766098 | Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. |
| Q58585648 | Longitudinal Study on Low-Dose Aspirin versus Placebo Administration in Silent Brain Infarcts: The Silence Study |
| Q92787993 | Sex-specific association of metabolic risk factors with brain ischemic lesions by severity and location |
| Q28077809 | Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives |
Search more.